2.4 semaglutide to tirzepatide (MOUNJARO, SEJARO) is a new class of medicine for the treatment of obesity and type 2 diabetes. This medicine is more advanced than (Ozempic and Semavic). It is a dual Switching from semaglutide to tirzepatide

Informacje zawarte w opisie nie zostay zatwierdzone przez GIS, GIF ani EFSA

If youre tired of spinning your wheels and ready to take control of your weight, your health, and your energy, its time for action

However, the key is early detection, followed by prompt action

Find out how IWL can help you keep the weight off permanently

PMID: Summary Keywords biologic therapy, early psoriatic arthritis, GLP-1 receptor agonists, inflammation, metabolic syndrome, psoriasis Citation Ciancio G, Maranini B, Sandri G, Amati G, Bortoluzzi A, Silvagni E, Govoni M and Giuggioli D (2026) Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities

For people struggling with obesity or weight-related health risks, GLP-1 medications have emerged as highly effective solutions